Not quite sure why you interpret announcing 250 as a distraction, @Red Tempura. Interesting conclusion.
Both drugs in 200 are safe in humans. In vitro tests prove it works. The rat model was a success. Actually, even more so as it was shown to protect the podocytes as well as decreasing proteinuria.
I'm as much a so-called conspiracy theorist as the next guy, so it's a curious summary.
But when I hear hoof beats, I tend not to think of zebras.
Ann: Outcomes of DMX-200 pre-IND meeting with the FDA-DXB.AX, page-43
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
0.040(8.89%) |
Mkt cap ! $269.6M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 50.5¢ | 46.0¢ | $2.255M | 4.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.5¢ | 21052 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |